Activated Protein C Utilises Protease Activated Receptors And Epidermal Growth Factor Receptor To Heal Wounds
Funder
National Health and Medical Research Council
Funding Amount
$436,882.00
Summary
Chronic leg ulcers are a major burden to the individual sufferer and to the health system. We have discovered that activated protein C (APC) potently stimulates wound healing in the laboratory and now have exciting positive results from a small pilot clinical trial showing that applying APC solution to leg ulcers also helps healing in patients. This study plans to discover how APC works at the molecular level.
Compounded by massive global food and water shortages, neglected tropical disease (NTD) pathogens have a devastating and long-term impact on billions of humans worldwide. Unlocking the fundamental molecular biology of these pathogens, particularly carcinogens, employing a raft of Frontier Technologies, will lead to new ways of controlling NTDs and will have substantial outcomes through the development of new drugs, vaccines and/or diagnostic tests. We will use cutting-edge molecular technologies ....Compounded by massive global food and water shortages, neglected tropical disease (NTD) pathogens have a devastating and long-term impact on billions of humans worldwide. Unlocking the fundamental molecular biology of these pathogens, particularly carcinogens, employing a raft of Frontier Technologies, will lead to new ways of controlling NTDs and will have substantial outcomes through the development of new drugs, vaccines and/or diagnostic tests. We will use cutting-edge molecular technologies to tackle this area head-on.Read moreRead less
Using Metagenomics To Determine The Causative Agent(s) Of Tick-Borne Disease In Australia
Funder
National Health and Medical Research Council
Funding Amount
$639,428.00
Summary
Tick-borne disease has emerged as a topical and controversial public health problem in Australia. We will employ state-of-the-art techniques in metagenomics to determine what microbial species (bacteria, viruses and eukaryotes) circulate in Australian ticks and whether these or different microbes are also present in humans diagnosed with tick-borne disease. The data generated will provide key information on whether tick-borne disease has a microbiological cause and, if so, the microbes involved.
Glutathione Transferase-derived Compounds As Therapeutic Agents
Funder
National Health and Medical Research Council
Funding Amount
$418,516.00
Summary
Inhibition of cardiac calcium ion channels may be an effective new way of improving heart performance in patients with heart failure. This project will investigate how a glutathione transferase enzyme inhibits calcium ion channels in the heart and if small fragments of a muscle specific glutathione transferase can be used to specifically modify cardiac ryanodine receptor function. These fragments will provide the basis for the development of a new therapeutic approach.
Overcoming Breast Cancer Heterogeneity And Resistance Using A Novel Therapeutic Approach Targeting The Metastasis Suppressor NDRG1.
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Breast cancer (BrCa) is the leading cause of cancer death in women and current treatments suffer from development of resistance, leading to metastatic progression. I will assess a novel treatment strategy for BrCa, targeting a gene that is able to inhibit multiple key drivers of BrCa, using a novel potent and selective anti-cancer agent. This approach has the potential to overcome resistance to current therapies and alleviate the onset of metastasis, to improve prognosis for BrCa patients.
I am a medical epidemiologist investigating links between specific infectious agents and specific types of cancer in immune deficient populations. Through the exploration of these relationships, my research aims to allow the prevention of these types of c